SEC Form 4 · Insider disclosures

Insider Trading Tracker

Who bought, who sold, and the disclosed plans and ownership context behind recent SEC Form 4 filings.

Updates are delayed; the last verified disclosures remain available.

Purchase rows367
Sale rows1,488
Purchase value (USD)US$441.64M
Sale value (USD)US$1.31B

Last 10 days of filings·Updated Oct 24, 3:10 AM ET

Recent company disclosures

31 companies · 107 rows
JOF

JAPAN SMALLER CAPITALIZATION FUND INC

Total value ≈ US$713.82K

3 transaction rows · 2 filings

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 16,222 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.71M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$193.69K

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 30,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.74M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$358.2K
Show 1 more transaction rows

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 13,133 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.48%; approximately 2.7M shares afterward

Calculated transaction value approximately US$161.93K
LASR

NLIGHT, INC.

Total value ≈ US$153.91K

1 transaction rows · 1 filings

MOORE GEOFFREY

Sale
Director disclosed sale of 4,452 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 5.19% of prior direct holdings; approximately 81.3K shares remain

Calculated transaction value approximately US$153.91K
GRX

Gabelli Healthcare & WellnessRx Trust

Total value ≈ US$1.98K

1 transaction rows · 1 filings

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 200 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately <0.01%; approximately 2.17M shares afterward

Calculated transaction value approximately US$1.98K
LNBIX

Lincoln Bain Capital Total Credit Fund

Total value ≈ US$25M

1 transaction rows · 1 filings

Lincoln Financial Investments Corp

Purchase
10% owner disclosed purchase of 2,477,700.69 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 8.80%; approximately 30.6M shares afterward

Calculated transaction value approximately US$25M
NONE

Sterling Real Estate Trust

Total value ≈ US$27K

2 transaction rows · 2 filings

Wieland James

Purchase
10% owner disclosed purchase of 980.3921 shares

Filing did not check the 10b5-1 plan indicator

Approximately 217K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$25K

Carlson Michael Paul

Purchase
Officer disclosed purchase of 78.4313 shares

Filing did not check the 10b5-1 plan indicator

Approximately 625 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2K
APLD

Applied Digital Corp.

Total value ≈ US$7.35M

3 transaction rows · 3 filings

Cummins Wes

Purchase
CEO / Director disclosed purchase of 55,803 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.95%; approximately 5.87M shares afterward

Calculated transaction value approximately US$1.01M

Zhang Jason Gechen

Purchase
Officer disclosed purchase of 300,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 11.81%; approximately 2.84M shares afterward

Calculated transaction value approximately US$5.66M
Show 1 more transaction rows

Nottenburg Richard N

Sale
Director disclosed sale of 31,250 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 23.42% of prior direct holdings; approximately 102K shares remain

Calculated transaction value approximately US$682.5K
ELTP

ELITE PHARMACEUTICALS INC /NV/

Total value ≈ US$25.98K

1 transaction rows · 1 filings

Dash Barry H

Purchase
Director disclosed purchase of 100,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 3.06%; approximately 3.37M shares afterward

Calculated transaction value approximately US$25.98K
BLLN

BillionToOne, Inc.

Total value ≈ US$1.09M

8 transaction rows · 1 filings

Atay Oguzhan

Sale
CEO / Director disclosed sale of 3,083 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 100 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$303.12K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 100 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.9K
Show 6 more transaction rows

Atay Oguzhan

Sale
CEO / Director disclosed sale of 900 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 4.25K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$88.59K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 1,861 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 2.39K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$185.81K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 1,276 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.11K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$128.37K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 980 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 133 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$99.75K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 133 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$13.67K

Atay Oguzhan

Sale
CEO / Director disclosed sale of 2,667 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 149K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$261.37K
RAL

Ralliant Corp

Total value ≈ US$913.02K

1 transaction rows · 1 filings

Newcombe Tamara S.

Sale
CEO / Director disclosed sale of 12,936 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 247K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$913.02K
WSM

WILLIAMS SONOMA INC

Total value ≈ US$200.2K

2 transaction rows · 1 filings

Finucane Anne A.

Sale
Director disclosed sale of 780 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 9.42K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$196.65K

Finucane Anne A.

Sale
Director disclosed sale of 14 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 9.4K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.54K
LIFE

Ethos Technologies Inc.

Total value ≈ US$9.15M

10 transaction rows · 2 filings

Wang Lingke

Sale
Officer / Director disclosed sale of 22,669 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.63M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$853.26K

Wang Lingke

Sale
Officer / Director disclosed sale of 94,864 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.65M
Show 8 more transaction rows

Wang Lingke

Sale
Officer / Director disclosed sale of 800 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$31.31K

Colis Peter George

Sale
CEO / Director disclosed sale of 31,900 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.55M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.24M

Colis Peter George

Sale
CEO / Director disclosed sale of 8,100 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$320.6K

Colis Peter George

Sale
CEO / Director disclosed sale of 8,165 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.57M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$307.33K

Colis Peter George

Sale
CEO / Director disclosed sale of 31,435 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.21M

Colis Peter George

Sale
CEO / Director disclosed sale of 400 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$15.65K

Colis Peter George

Sale
CEO / Director disclosed sale of 34,468 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.3M

Colis Peter George

Sale
CEO / Director disclosed sale of 5,532 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$211.99K
MPLT

MapLight Therapeutics, Inc.

Total value ≈ US$1.06M

6 transaction rows · 6 filings

Kreitzer Anatol

Sale
Officer disclosed sale of 12,248 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 6.76% of prior direct holdings; approximately 169K shares remain

Calculated transaction value approximately US$96.02K

GILLIS JONATHAN

Sale
CFO disclosed sale of 10,167 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 6.66% of prior direct holdings; approximately 142K shares remain

Calculated transaction value approximately US$82.15K
Show 4 more transaction rows

Lillie James Woodruff

Sale
Officer disclosed sale of 11,513 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 5.47% of prior direct holdings; approximately 199K shares remain

Calculated transaction value approximately US$93.03K

Hanson Kristopher

Sale
Officer disclosed sale of 9,020 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 6.58% of prior direct holdings; approximately 128K shares remain

Calculated transaction value approximately US$72.88K

Foff Erin Pennock

Sale
Officer disclosed sale of 15,355 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 4.91% of prior direct holdings; approximately 297K shares remain

Calculated transaction value approximately US$124.07K

Kroeger Christopher A.

Sale
CEO / Director disclosed sale of 73,691 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 5.80% of prior direct holdings; approximately 1.2M shares remain

Calculated transaction value approximately US$595.42K
Sources, coverage & updates
SEC filing dates: 2026-10-15 — 2026-10-24 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 24, 3:10 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,224 · Parsed 2,224 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 10 unavailable, unverified or non-USD amounts are excluded. 706 filings · 675 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗